Does Ozempic Help With Cholesterol Levels?

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Semaglutide Affects Cholesterol and Triglycerides

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that regulates blood sugar and appetite. When patients lose weight on this medication, their cholesterol levels often improve naturally due to reduced body fat and lower calorie intake. However, research suggests semaglutide may have direct effects on lipid metabolism independent of weight loss alone.

Clinical trials have documented meaningful reductions in triglycerides—a type of blood fat linked to heart disease risk—in patients using semaglutide. Some studies show triglyceride drops of 15–30% depending on baseline levels and the dose used. These improvements appear relatively consistent across different patient populations, from those with type 2 diabetes to people with obesity.

LDL cholesterol (often called 'bad cholesterol') and total cholesterol also tend to decrease in semaglutide users, though the magnitude varies. The combination of lower LDL and triglycerides while maintaining or slightly raising HDL ('good cholesterol') represents a favorable shift in cardiovascular risk factors.

Clinical Evidence: What Studies Show About GLP-1 and Heart Health

The SUSTAIN-6 trial, a landmark study published in 2016, examined semaglutide's cardiovascular effects in people with type 2 diabetes and existing heart disease or high risk. Participants taking semaglutide showed significant reductions in major cardiovascular events, including heart attack and stroke, compared to placebo. This study provided the first clear evidence that GLP-1 benefits extend beyond glucose control and weight loss.

More recent analyses have focused specifically on lipid changes. Patients on semaglutide therapy typically show triglyceride reductions of 10–25%, with some achieving even greater improvements when combined with lifestyle changes. HDL cholesterol (protective cholesterol) often remains stable or increases slightly, which further improves the overall lipid profile.

The cardiovascular protection observed in these trials likely results from multiple mechanisms: weight loss itself, direct effects on inflammation, improved blood vessel function, and favorable changes in lipid levels all working together to reduce disease risk.

Weight Loss and Cholesterol: The Connection Explained

Weight loss is one of the most powerful interventions for improving cholesterol levels, and semaglutide's primary action is appetite suppression that leads to sustained weight reduction. When patients lose 10–15% of their body weight, triglycerides often drop by 20–30%, and LDL cholesterol may decrease by similar percentages. This relationship holds true across different populations and ages.

The liver produces cholesterol and triglycerides based partly on how much excess fat the body stores. As semaglutide users lose weight, their bodies require less cholesterol production, naturally lowering blood levels. Additionally, reduced visceral fat (the dangerous fat stored around organs) has particularly strong effects on improving insulin sensitivity and lipid profiles.

It is important to note that weight loss benefits on cholesterol can plateau after 6–12 months if patients reach a stable new weight. However, semaglutide's effects on lipid metabolism appear to continue beyond the weight loss effect, suggesting the medication provides additive cardiovascular protection.

Personalized GLP-1 Therapy and Genetic Factors in Cholesterol Response

Not all patients respond identically to semaglutide, and genetic factors influence how effectively someone's cholesterol profile will improve. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights related to peptide response, including variants affecting lipid metabolism. Key variants such as GIPR rs1800437 can influence how your body responds to GLP-1 therapy.

Understanding your genetic predisposition to cholesterol changes allows PlexusDx to personalize your therapy selection and dosing strategy. Some patients may benefit more from compounded semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan), while others might achieve better lipid control with tirzepatide or combination protocols. The genetic test, available at $298, helps identify which peptide pathways are most active in your metabolism.

Personalized precision health means choosing the medication and starting dose that matches your unique genetic profile and metabolic needs—not a one-size-fits-all approach. This targeted strategy can lead to faster, more significant improvements in cholesterol and cardiovascular markers.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Does semaglutide directly lower cholesterol, or is it only from weight loss?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much can I expect my triglycerides to drop on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How does PlexusDx pricing work for semaglutide therapy?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) flat—your dose may need to go up, but your price won't. All formulations from licensed 503A compounding pharmacies are available in all 50 states with no insurance required, and treatment is HSA/FSA eligible.

Is it safe to use semaglutide if I have familial high cholesterol?

Semaglutide can be beneficial even in genetic cholesterol conditions, though it works best alongside medical management and lifestyle changes. Always discuss your personal and family cholesterol history with a healthcare provider before starting therapy. PlexusDx providers review your complete health history during the consultation process.

How does the Precision Peptide Genetic Test help with cholesterol management?

The test analyzes variants in genes affecting lipid pathways, including FTO rs9939609 and MC4R rs17782313, which influence how your body regulates weight, inflammation, and cholesterol production. These insights help PlexusDx match you to the most effective GLP-1 protocol—whether semaglutide, tirzepatide, or a dual-compound option—for optimal cardiovascular outcomes.

Related Reading

• Effects Of Fads12 Variants On Fat Metabolism And Cholesterol Levels
• Can A Genetic Test Provide Insights Into My Cholesterol Levels
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.